US Stock MarketDetailed Quotes

PHAT Phathom Pharmaceuticals

Watchlist
  • 4.250
  • -0.110-2.52%
Trading Apr 30 11:14 ET
296.01MMarket Cap-0.80P/E (TTM)

About Phathom Pharmaceuticals Company

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Company Profile

SymbolPHAT
Company NamePhathom Pharmaceuticals
Listing DateOct 25, 2019
Issue Price19.00
Founded2018
CEOMr. Steven L. Basta
MarketNASDAQ
Employees427
Fiscal Year Ends12-31
Address100 Campus Drive,Suite 102
CityFlorham Park
ProvinceNew Jersey
CountryUnited States of America
Zip Code07932
Phone1-877-742-8466

Company Executives

  • Name
  • Position
  • Salary
  • Steven L. Basta
  • Director, President and Chief Executive Officer
  • --
  • Tom Harris
  • Chief Development Sciences Officer
  • --
  • Martin Gilligan
  • Chief Commercial Officer
  • --
  • Molly Henderson
  • Principal Accounting Officer, Chief Financial and Business Officer
  • 1.42M
  • Azmi Nabulsi, M.D.
  • Chief Operating Officer
  • 1.57M
  • Michael F. Cola
  • Chairman of the Board
  • 343.60K
  • Theodore R. Schroeder
  • Independent Director
  • --
  • Heidi Kunz
  • Independent Director
  • 304.43K
  • Mark Stenhouse
  • Independent Director
  • 296.10K
  • Frank L. Karbe
  • Independent Director
  • 297.56K
  • David A. Socks
  • Independent Director
  • 294.64K
  • Dr. James N. Topper, M.D.,PhD
  • Independent Director
  • 284.43K
  • Dr. Asit Parikh, M.D.,PhD
  • Independent Director
  • 296.93K

Market Insights

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More